Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | EPOR | P19235 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15375596 | 0.88 | LTA4H (0.46) | LTA4HRAB9ANPC1MAPTKMT2A | |
| SCHEMBL15375350 | 0.87 | MAOB (0.45) | LTA4HRAB9ANPC1MAPTFFAR4 | |
| SCHEMBL15401872 | 0.86 | RXRA (0.44) | LTA4HRAB9ANPC1HSP90AA1MAPT | |
| SCHEMBL15375443 | 0.86 | SCN9A (0.48) | RAB9ANPC1HSP90AA1MAPTL3MBTL1 | |
| SCHEMBL15402157 | 0.85 | RXRA (0.45) | LTA4HRAB9ANPC1L3MBTL1RXRA | |
| SCHEMBL15402607 | 0.84 | ADRB2 (0.38) | LTA4HRAB9AMAPTFFAR4KMT2A | |
| SCHEMBL15401894 | 0.84 | ADRB2 (0.38) | RAB9AMAPTFFAR4FFAR1KDM4E | |
| SCHEMBL15402289 | 0.84 | KMT2A (0.48) | LTA4HRAB9ANPC1MAPTRXRA | |
| SCHEMBL15401843 | 0.83 | FABP4 (0.44) | LTA4HRAB9AMAPTL3MBTL1KMT2A | |
| SCHEMBL15375381 | 0.83 | MAPT (0.45) | MAPTL3MBTL1KMT2AKDM4EADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2682382-B1 | Method for Producing Phenylacetamide Compound | SUMITOMO CHEMICAL CO (JP) | 2016-11-23 | — | — | EP | disclosed |
| CN-103588657-B | The manufacture method of phenylacetyl amines | 住友化学株式会社 | 2016-06-22 | — | — | CN | disclosed |
| EP-2397459-B1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2015-12-16 | — | — | EP | disclosed |
| CN-103641731-B | The manufacture method of phenylacetyl amine compound | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-10-28 | — | — | CN | disclosed |
| CN-103588657-A | Method for producing phenylacetamide compound | SUMITOMO CHEMICAL CO | 2014-02-19 | — | — | CN | disclosed |
| EP-2682382-A2 | Method for Producing Phenylacetamide Compound | Sumitomo Chemical Company, Limited (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-8624062-B2 | Method for producing phenylacetamide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-07 | — | — | US | disclosed |
| EP-2662352-A2 | Method for Producing Phenylacetamide Compound | Sumitomo Chemical Company, Limited (JP) | 2013-11-13 | — | — | EP | disclosed |
| CN-102348677-A | Method for producing phenylacetamide compound | SUMITOMO CHEMICAL CO | 2012-02-08 | — | — | CN | disclosed |
| EP-2397459-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110295035-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110295035-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | MRPL21, AADAC, ARSA | LTA4H 4078/4885RAB9A 1780/4885NPC1 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.